| Across |
| 1. | Acute issue involving myeloid cell proliferation; mostly white blood cells overloading |
| 5. | Most common childhood leukemia |
| 7. | Type of count in lab to determine neutrophil levels; good predictor of immune response to infection |
| 10. | Method of acquiring sickle cell disease |
| 11. | Inherited disorder involving B and T cells communication breakdown leading to neurologic motor dysfunction and vascular lesions |
| 12. | Immunodeficiency for which cause cannot be determined readily |
| 15. | Cellular feasting |
| 16. | Lower dose chemo than induction; designed to eradicate what's left of problematic cells |
| 17. | crystalline deposits of uric acid in joints |
| 20. | Rheumatic disease with tophi as a key characteristic |
| 21. | One type of transfusion complication |
| 22. | Platelet daddy |
| 25. | Patients with Hodgkin's at high risk for developing these cancers |
| 26. | Cause for many of the secondary immunodeficiencies and blood disorders discussed; not medication but the other |
| 27. | Overreaction of the body to foreign substance like latex |
| 28. | Reed-Sternberg cells noted |
| 31. | Steroids, Biologics, Calcineurin inhibitors, Monoclonal antibody medications |
| 32. | increase in this compound creates characteristic tough skin appearance with reduced elasticity |
| 35. | Malignant plasma cells |
| 36. | Immune response initiated by T cells |
| 37. | Seen in patients with B12 deficiency sometimes; numbness or tingling |
| 42. | Gout |
| 44. | One disease causing malabsorption; may lead to deficiencies |
| 45. | Electrolyte imbalance noted in Tumor lysis syndrome; requires kayexelate or medication "cocktail" to address |
| 46. | surgery to reduce tear loss in Sjogren's |
| 47. | Coating with slimy/sticky stuff for easier cellular feasting |
| 48. | Severe combined immunodeficiency disease |
| 49. | Born in the marrow, grow in the marrow |
| 50. | Weight loss, diaphoresis, fatigue |